Clinical outcomes of hepatitis B virus (HBV) genotypes B and C in Japanese patients with chronic HBV infection

American Journal of Tropical Medicine and Hygiene

Volumn 67, Issue 2 SUPPL., 2002, Pages 151-157

  Furusyo, Norihiro ^a   Nakashima, Hisashi ^a   Kashiwagi, Kenichiro ^a   Kubo, Norihiko ^a   Hayashida, Kazuhiro ^a   Usuda, Sadakazu ^a   Mishiro, Shunji ^a   Kashiwagi, Seizaburo ^a   Hayashi, Jun ^a  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B(E) ANTIGEN; INTERFERON; VIRUS DNA;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; CHRONIC HEPATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GENE AMPLIFICATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYBRIDIZATION; INFANT; INFECTION RATE; JAPAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATHOGENICITY; SEROLOGY; VIRUS DETECTION; VIRUS IDENTIFICATION; VIRUS REPLICATION;

DNA VIRUSES; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 0036698229     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2002.67.151     Document Type: Article

References (35)

1. Maynard JE, 1990. Hepatitis B: global importance and need for control. Vaccine 8 (suppl): S18-20.
2. Lai CL, 1997. Chronic hepatitis B in Hong Kong: immunization strategies for the control of hepatitis B virus infection. Zuckerman AJ, ed. Hepatitis B in the Asian-Pacific Region, Screening, Diagnosis and Control. Volume 1. London: Royal College of Physicians of London, 79-87.
3. Kashiwagi S, Hayashi J, Ikematsu H, Nomura H, Kajiyama W, Shingu T, Hayashida K, Kaji M, 1984. Transmission of hepatitis B virus among siblings. Am J Epidemiol 120: 617-625.
4. Kashiwagi S, Hayashi J, Ikematsu H, Nomura H, Kusaba T, Shingu T, Hayashida K, Kaji M, 1983. An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan. Am J Epidemiol 118: 787-794.
5. Hayashi J, Kashiwagi S, Nomura H, Kajiyama W, Ikematsu H, 1987. Hepatitis B virus transmission in nursery schools. Am J Epidemiol 125: 492-498.
6. Hayashi J, Kajiyama W, Noguchi A, Ikematsu H, Nomura H, Nakashima K, Morofuji M, Kashiwagi S, 1990. Marked decrease of hepatitis B virus infection among children in Okinawa, Japan. Int J Epidemiol 19: 1083-1085.
7. Furusyo N, Hayashi J, Sawayama Y, Kawakami Y, Kishihara Y, Kashiwagi S, 1998. The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan over a 26-year period. Am J Trop Med Hyg 59: 693-698.
8. Dodd RY, Holland PV, Ni LY, Smith HM, Greenwalt TJ, 1973. Hepatitis B antigen: regional variation in incidence and subtype ratio in the American Red Cross donor population. Am J Epidemiol 97: 111-115.
9. Kashiwagi S, Hayashi J, Ikematsu H, Nishigori S, Ishihara K, Kaji M, 1982. An outbreak of hepatitis B in members of a high school sumo wrestling club. JAMA 248: 213-214.
10. Noguchi A, Hayashi J, Nakashima K, Hirata M, Ikematsu H, Kashiwagi S, 1994. HBsAg subtypes among HBsAg carriers in Okinawa, Japan. Evidence of an important relationship in seroconversion from HBeAg to anti-HBe. J Infect 28: 141-150.
11. Carman W, Thomas H, Domingo E, 1993. Viral genetic variation: hepatitis B virus as a clinical example. Lancet 341: 349-353.
12. Okamoto H, Tsuda F, Sakugawa H, Sastrosoewignjo, RI, Imai M, Miyakawa Y, Mayumi M, 1988. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69: 2575-2583.
13. Norder H, Courouce AM, Magnius LO, 1994. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198: 489-503.
14. Arauz-Ruiz P, Norder H, Visona KA, Magnius LO, 1997. Genotype F prevails in HBV infected patients of hispanic origin in Central America and may carry the precore stop mutant. J Med Virol 51: 305-312.
15. Norder H, Hammas B, Lee SD, Bile K, Courouce AM, Mushahwar IK, Magnius LO, 1993. Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigen. J Gen Virol 74: 1341-1348.
16. Stuyver L, De Gendt S, van Geyt C, Zoulim F, Fried M, Schinazi RF, Rossau R, 2000. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol. 81: 67-74.
17. Furusyo N, Hayashi J, Sawayama Y, Kishihara Y, Kashiwagi S, 1999. Hepatitis B surface antigen disappearance and hepatitis B surface antigen subtype: a prospective, long-term, follow-up study of Japanese residents of Okinawa, Japan with chronic hepatitis B virus infection. Am J Trop Med Hyg 60: 616-622.
18. Usuda S, Okamoto H, Iwanari H, Baba K, Tsuda F, Miyakawa Y, Mayumi M, 1999. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods 80: 97-112.
19. Ide T, Kumashiro R, Hino T, Murashima S, Ogata K, Koga Y, Sata M, 2001. Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine. Hepatol Res 21: 76-84.
20. Magnius LO, Norder H, 1995. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38: 24-34.
21. Lindh M, Andersson AS, Gusdal A, 1997. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus-large-scale analysis using a new genotyping method. J Infect Dis 175: 1285-1293.
22. Chan HL, Hussain M, Lok AS, 1999. Different hepatitis B virus genotypes are associated with different mutations in the core promoter and precore regions during hepatitis B e antigen seroconversion. Hepatology 29: 976-984.
23. Kao JH, Wu NH, Chen PJ, Lai MY, Chen DS, 2000. Hepatitis B genotypes and the response to interferon therapy. J Hepatol 33: 998-1002.
24. Orito E, Mizokami M, Sakugawa H, Michitaka K, Ishikawa K, Ichida T, Okanoue T, Yotsuyanagi H, Iino S, 2001. A casecontrol study for clinical and molecular biologic differences between hepatitis B viruses of genotypes B and C. Hepatology 33: 218-223.
25. Lindh M, Hannoun C, Dhillon AP, Norkrans G, Horal P, 1999. Core promoter mutations and genotypes in relation to viral replication and liver damage in East Asian hepatitis B virus carriers. J Infect Dis 179: 775-782.
26. Hayashi J, Kashiwagi S, Ikematsu H, Nomura H, Kajiyama W, Noguchi A, Ikeda K, 1988. Sex- and age-specific prevalences of HBeAg and anti-HBe among HBsAg carriers with or without liver function abnormalities in Okinawa, Japan. Microbiol Immunol 32: 843-850.
27. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC Jr, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J, Gibas A, 1990. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 323: 295-301.
28. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J, 1993. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 119: 312-323.
29. Carman WF, Jacyna MR, Hadziyannis S, Karayiannis P, McGarvey MJ, Makris A, Thomas HC, 1989. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 2: 588-591.
30. Davis GL, Hoofnagle JH, Waggoner JG, 1984. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 86: 230-235.
31. Okamoto H, Yotsumoto S, Akahane Y, Yamanaka T, Miyazaki Y, Sugai Y, Tsuda F, Tanaka T, Miyakawa Y, Mayumi M, 1990. Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol 64: 1298-1303.
32. Akahane Y, Yamanaka T, Suzuki H, Sugai Y, Tsuda F, Yotsumoto S, Omi S, Okamoto H, Miyakawa Y, Mayumi M, 1990. Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology 99: 1113-1119.
33. Mangia A, Chung YH, Hoofnagle JH, Birkenmeyer L, Mushahwar I, Di Bisceglie AM, 1996. Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg. Dig Dis Sci 41: 2447-2452.
34. Pichoud C, Berby F, Stuyver L, Petit MA, Trepo C, Zoulim F, 2000. Persistence of viral-replication after anti-HBe seroconversion during antiviral therapy for chronic hepatitis B. J Hepatol 32: 307-316.
35. Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB, 1981. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Ann Intern Med 94: 744-748.